Collectively, these observations suggest that Wallerian-like mechanisms could contribute to the neurodegeneration seen in motor neuron diseases, and that depletion of SARM1 could have therapeutic potential in ALS. This evidence concerns the gene SARM1 and amyotrophic lateral sclerosis.